Delivery Order SPE2DR25D3201-SPE2DR26FT4AR
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,187.10 to AmerisourceBergen Drug Corp for Aranespâ„¢ 300 micrograms/0.6 milliliter syringes on November 4, 2025, with completion targeted for November 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,428.42 to AmerisourceBergen Drug Corp for the supply of Aranespâ„¢ 60 mcg/0.3 mL syringes on November 4, 2025, with a completion date of November 5, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to this major pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery operations from its corporate...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,531.43 on October 29, 2025, for the supply of Aranespâ„¢ 40 mcg/0.4 mL syringes. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by October 30, 2025. The work will be performed at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Aranespâ„¢ 200 mcg/0.4 mL syringes valued at $5,577.42 with a completion date of October 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The product will be delivered to AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, supporting federal medical procurement needs for...
- The Defense Logistics Agency awarded a $14,273.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Aranespâ„¢ 500 mcg/1 mL syringes, with an ultimate completion date of October 28, 2025. This is a non-set-aside competitive award issued to support federal medical procurement needs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and veteran healthcare systems through its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aranesp 100 mcg/0.5 ml syringes, with a ceiling value of $17,119.62 under a firm fixed price arrangement. The contract, which was competitively awarded without set-aside designation, has an ultimate completion date of October 28, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Aranesp is an erythropoiesis-stimulating agent used primarily in the treatment of anemia...
- The Defense Logistics Agency awarded a $20,751.20 delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Aranesp 500 mcg/1 mL syringes. This is a firm fixed-price, non-set-aside contract with a completion date of July 29, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Aranespâ„¢ 150 MCG/0.3 mL syringes, with a ceiling value of $1,477.12. This is a firm fixed-price delivery order with an ultimate completion date of October 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No small business set-aside was applied to this award, indicating it was competitively awarded on an unrestricted...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,437.05 for Aransesp 40 mcg/0.4 mL syringes on April 22, 2025, with completion scheduled for April 23, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999.99 million through December 2026. The pharmaceutical...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Aranespâ„¢ 40 mcg/0.4 mL syringes, with a ceiling value of $3,786.66 and an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single line item fulfillment...
- SPE2DR25D3201Indefinite Delivery Contract
- SPE2DR25D3201-SPE2DR26FT4ARDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Aranesp 300 mcg/0.6 mL syringes valued at $3,132.42 with a firm fixed price structure. The order, issued on November 14, 2025, requires completion by November 17, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply delivery, leveraging its extensive federal procurement experience as a major healthcare solutions provider and pharmaceutical distributor. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. This particular delivery order for Aranesp, an erythropoiesis-stimulating agent used in anemia treatment, exemplifies the contractor's role in fulfilling critical medical supply needs across the Defense Health Agency and other federal healthcare systems.